| __timestamp | Regeneron Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1271353000 | 19586000 |
| Thursday, January 1, 2015 | 1620577000 | 29135000 |
| Friday, January 1, 2016 | 2052295000 | 42791000 |
| Sunday, January 1, 2017 | 2075142000 | 49577000 |
| Monday, January 1, 2018 | 2186100000 | 89209000 |
| Tuesday, January 1, 2019 | 3036600000 | 69099000 |
| Wednesday, January 1, 2020 | 2735000000 | 75961000 |
| Friday, January 1, 2021 | 2908100000 | 90467000 |
| Saturday, January 1, 2022 | 3592500000 | 74552000 |
| Sunday, January 1, 2023 | 4439000000 | 91593000 |
| Monday, January 1, 2024 | 5132000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. exemplify two distinct approaches to research and development (R&D) spending. Over the past decade, Regeneron has consistently prioritized innovation, with R&D expenses growing by an impressive 250% from 2014 to 2023. In contrast, Supernus has shown a more modest increase of around 370% in the same period, albeit from a much smaller base.
Regeneron's commitment to innovation is evident, with R&D spending peaking at $4.4 billion in 2023, a stark contrast to Supernus's $91.6 million. This disparity highlights Regeneron's aggressive strategy to lead in pharmaceutical advancements. As the industry evolves, these spending patterns may shape the future landscape of drug development and patient care.
Research and Development Investment: Pfizer Inc. vs Supernus Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Regeneron Pharmaceuticals, Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Ultragenyx Pharmaceutical Inc. or Supernus Pharmaceuticals, Inc.: Who Invests More in Innovation?
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Catalyst Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.